comparemela.com

Penumbra (NYSE:PEN – Get Rating) was downgraded by Zacks Investment Research from a “hold” rating to a “strong sell” rating in a note issued to investors on Wednesday, Zacks.com reports. According to Zacks, “Penumbra, Inc. is an interventional therapies company. It designs, develops, manufactures and markets medical devices. The company’s portfolio of products primarily addresses […]

Related Keywords

Australia ,California ,United States ,Canada ,Johanna Roberts ,Penumbra Inc ,Securities Exchange Commission ,Zacks Investment Research ,Amundi Pioneer Asset Management Inc ,Deutsche Bank Aktiengesellschaft ,Needham Company ,Sg Americas Securities ,Jpmorgan Chase Co ,Lisanti Capital Growth ,Raymond James Associates ,Citigroup ,Get Rating ,Neurovascular Access ,Neuron Access System ,Access System ,Penumbra System ,Penumbra Coil ,Ruby Coil System ,Penumbra Occlusion Device ,Exchange Commission ,Pioneer Asset Management ,Capital Growth ,Revascularization Device ,Penumbra ,Nyse Pen ,Pen ,Medical ,Downgrade ,

© 2024 Vimarsana

comparemela.com © 2020. All Rights Reserved.